Literature DB >> 6207166

Serum-resistant mutants of Escherichia coli O111 contain increased lipopolysaccharide, lack an O antigen-containing capsule, and cover more of their lipid A core with O antigen.

R C Goldman, K Joiner, L Leive.   

Abstract

Escherichia coli strains of group O111 were characterized with respect to sensitivity to complement killing, amount of lipopolysaccharide and O antigen-containing capsule, and distribution of O antigen. All wild-type E. coli O111 strains were resistant to complement killing in the absence of specific antibody. Presensitization of strains with antibody to whole cells (OK antibody), followed by incubation in 50% pooled normal human serum as a source of complement, subdivided wild-type strains into three types: completely resistant, partially resistant, and sensitive. Completely and partially resistant mutants were isolated by cycles of serum killing, starting with one sensitive strain. Completely resistant mutants had no O antigen-containing capsule, but had 50% more lipopolysaccharide than did the parent, and this lipopolysaccharide had 30% fewer lipid A core molecules devoid of O antigen. Partially resistant mutants still had O antigen-containing capsule, but contained 40% more lipopolysaccharide than did the parent; the extent of coverage of lipid A core with O antigen remained unchanged. No correlations were found between outer membrane protein composition and the degree of serum resistance. Since the terminal membrane attack complex (C5b-9) must stably insert into a hydrophobic membrane site to effect killing, we conclude that both increased lipid A core and increased coverage of lipid A core with O antigen preclude access of C5b-9 to lethal sites on the cell surface.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6207166      PMCID: PMC215740          DOI: 10.1128/jb.159.3.877-882.1984

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  30 in total

1.  The survival of strains of enteric bacilli in the blood stream as related to their sensitivity to the bactericidal effect of serum.

Authors:  R J ROANTREE; N C PAPPAS
Journal:  J Clin Invest       Date:  1960-01       Impact factor: 14.808

2.  Killing of an encapsulated strain of Escherichia coli by human serum.

Authors:  P W Taylor; H P Kroll
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

3.  Interaction of complement components with a serum-resistant strain of Salmonella typhimurium.

Authors:  B L Reynolds; U A Rother; K O Rother
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

4.  Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing.

Authors:  K Joiner; E Brown; C Hammer; K Warren; M Frank
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

5.  HeLa cell invasiveness and O antigen of Shigella flexneri as separate and prerequisite attributes of virulence to evoke keratoconjunctivitis in guinea pigs.

Authors:  N Okamura; T Nagai; R Nakaya; S Kondo; M Murakami; K Hisatsune
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

6.  Induction of bacteremia in newborn rats by Escherichia coli K1 is correlated with only certain O (lipopolysaccharide) antigen types.

Authors:  G Pluschke; A Mercer; B Kusećek; A Pohl; M Achtman
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

7.  Quantitative double-label radiography of two-dimensional protein gels using color negative film and computer analysis.

Authors:  R C Goldman; B L Trus; L Leive
Journal:  Eur J Biochem       Date:  1983-04-05

8.  Plasmid-determined resistance to serum bactericidal activity: a major outer membrane protein, the traT gene product, is responsible for plasmid-specified serum resistance in Escherichia coli.

Authors:  A Moll; P A Manning; K N Timmis
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

9.  Determinants that increase the serum resistance of Escherichia coli.

Authors:  P W Taylor; M K Robinson
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

10.  Characterization of complement resistance in Escherichia coli conferred by the antibiotic resistance plasmid R100.

Authors:  R T Ogata; R P Levine
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

View more
  46 in total

1.  Increased Pho regulon activation correlates with decreased virulence of an avian pathogenic Escherichia coli O78 strain.

Authors:  Nicolas Bertrand; Sébastien Houle; Guillaume LeBihan; Édith Poirier; Charles M Dozois; Josée Harel
Journal:  Infect Immun       Date:  2010-10-04       Impact factor: 3.441

2.  Mechanism of O-antigen distribution in lipopolysaccharide.

Authors:  R C Goldman; F Hunt
Journal:  J Bacteriol       Date:  1990-09       Impact factor: 3.490

Review 3.  Escherichia coli in extra-intestinal infections.

Authors:  I Orskov; F Orskov
Journal:  J Hyg (Lond)       Date:  1985-12

4.  Transient shielding of intimin and the type III secretion system of enterohemorrhagic and enteropathogenic Escherichia coli by a group 4 capsule.

Authors:  Yulia Shifrin; Adi Peleg; Ophir Ilan; Chen Nadler; Simi Kobi; Kobi Baruch; Gal Yerushalmi; Tatiana Berdichevsky; Shoshy Altuvia; Maya Elgrably-Weiss; Cecilia Abe; Stuart Knutton; Chihiro Sasakawa; Jennifer M Ritchie; Matthew K Waldor; Ilan Rosenshine
Journal:  J Bacteriol       Date:  2008-05-23       Impact factor: 3.490

5.  Interaction of complement with serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa.

Authors:  N L Schiller; K A Joiner
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

6.  The wzz (cld) protein in Escherichia coli: amino acid sequence variation determines O-antigen chain length specificity.

Authors:  A V Franco; D Liu; P R Reeves
Journal:  J Bacteriol       Date:  1998-05       Impact factor: 3.490

7.  Comparative immunogenicity of conjugates composed of Escherichia coli O111 O-specific polysaccharide, prepared by treatment with acetic acid or hydrazine, bound to tetanus toxoid by two synthetic schemes.

Authors:  R K Gupta; W Egan; D A Bryla; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

8.  Mechanism of resistance to complement-mediated killing of bacteria encoded by the Salmonella typhimurium virulence plasmid gene rck.

Authors:  E J Heffernan; S Reed; J Hackett; J Fierer; C Roudier; D Guiney
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

9.  Surface exposure of outer membrane protein and lipopolysaccharide epitopes in Brucella species studied by enzyme-linked immunosorbent assay and flow cytometry.

Authors:  R A Bowden; A Cloeckaert; M S Zygmunt; S Bernard; G Dubray
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

10.  TnphoA-mediated disruption of K54 capsular polysaccharide genes in Escherichia coli confers serum sensitivity.

Authors:  T A Russo; M C Moffitt; C H Hammer; M M Frank
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.